This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between these …

This is the sixth special report that the European Society for Blood and Marrow Transplantation
regularly publishes on the current practice and indications for haematopoietic SCT for …

Background First-line pembrolizumab monotherapy improves overall and progression-free
survival in patients with untreated metastatic non-small-cell lung cancer with a programmed …

The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria
for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The …

Tuberculosis control relies on the identification and preventive treatment of individuals who
are latently infected with Mycobacterium tuberculosis. However, direct identification of latent …

Background Cytomegalovirus (CMV) infection remains a common complication after allogeneic
hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–…

Purpose: This phase III study compared docetaxel and doxorubicin in patients w ith metastatic
breast cancer w ho had received previousalkylating agent–containing chemotherapy. …

Anti-tumour necrosis factor (TNF) monoclonal antibodies or soluble TNF receptors have
become an invaluable treatment against chronic inflammatory diseases, such as rheumatoid …

Background Patients with hematological malignancies (HM) are at high risk of mortality from
SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse …